Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture between Zydus Lifesciences Limited and Takeda Pharmaceutical Company Limited, is celebrating the 25th anniversary of its Vashi manufacturing plant in India. The milestone underscores the company's dedication to producing high-quality active pharmaceutical ingredients (APIs) and intermediates, which play a vital role in life-transforming treatments for patients worldwide.

Over the past quarter-century, the Vashi facility has emerged as a key supplier of APIs and intermediates for Takeda’s markets across Europe, Japan, Brazil, and Korea. Operating as a 100% export-oriented unit, the plant has consistently prioritized safety, quality, and efficiency. Throughout its journey, the site has successfully executed capacity expansions and multiple technology transfers for essential Takeda small-molecule products, cementing its place as a crucial node in Takeda’s global supply chain.

Looking ahead, Zydus Takeda is focused on enhancing the plant’s role within Takeda’s strategic manufacturing network. Future initiatives include expanding the product portfolio with new APIs and key starting materials, upgrading kilo lab facilities, and integrating renewable energy solutions to align with Takeda’s net-zero emissions goal. Additionally, the company plans to invest in digital automation technologies to improve efficiency and minimize waste, while refining supply chain strategies to strengthen global collaboration. Employee engagement and sustainability will also remain at the forefront, with continuous learning programs and health-driven initiatives aimed at fostering an environmentally responsible work culture.

Reflecting on the landmark occasion, Thomas Wozniewski, Global Manufacturing and Supply Officer at Takeda and Chairman and Director on the Board of Zydus Takeda, expressed gratitude for the successful partnership between Zydus and Takeda. "We are grateful for our strong collaboration with Zydus, which has been instrumental in serving patients worldwide. Over the past 25 years, the dedication of our colleagues at Vashi has made the site an integral part of Takeda’s network. Their unwavering commitment to quality, safety, and sustainability will continue to drive the success of this manufacturing facility," he stated.

Pankaj R. Patel, Chairman of Zydus Lifesciences and Director on the Board of Zydus Takeda, highlighted the importance of long-term partnerships in fostering industrial growth. "At Zydus, we have always believed in nurturing collaborations that create shared success. This milestone marks a significant chapter in a partnership that has evolved over the decades. We remain committed to maintaining the highest standards of quality and precision in manufacturing excellence, which continue to be the foundation of our joint venture. As we move forward, we will explore new avenues for growth and innovation," he added.

Beyond manufacturing, the 25th anniversary celebration also honors the dedicated team at Vashi, whose expertise and adaptability have played a crucial role in the plant’s achievements. Their commitment to patient-centricity, innovation, collaboration, and ethical business practices aligns with the shared values of Zydus and Takeda. As Zydus Takeda embarks on the next phase of its journey, the company remains steadfast in its mission to contribute to global healthcare solutions while upholding the highest standards of sustainability, integrity, and excellence.